Phosphorylation-dependent and -independent functions of p130 cooperate to evoke a sustained G1 block

被引:85
作者
Hansen, K
Farkas, T
Lukas, J
Holm, K
Rönnstrand, L
Bartek, J
机构
[1] Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark
[2] Ludwig Inst Canc Res, Biomed Ctr, S-75124 Uppsala, Sweden
关键词
cyclins; E2F4; G(1) arrest; p130; phosphorylation;
D O I
10.1093/emboj/20.3.422
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The retinoblastoma (pRb)-related p130 pocket protein is a regulator of cell growth and differentiation, and a candidate tumour suppressor. Both pRb and p130 operate through interactions with cellular proteins, including the E2F transcription factors. While such interactions are controlled by phosphorylation of multiple sites of pRb, regulation of p130 remains poorly understood. We now identify 22 in vivo phosphorylation sites of p130, targeted by diverse kinases, and present evidence for three cyclin-dependent kinase 4(6) [Cdk4(6)] specific phosphorylations, which appear critical for controlling the growth-restraining activity of p130, When expressed in U20S cells, the phosphorylation-deficient mutant p130(Delta Cdk4), in which the Cdk4 specific sites were mutated to alanine residues, imposed a more sustained G(1) arrest than a constitutively active pRb(Delta Cdk), known to repress all cellular E2F activity. Experiments using p130(Delta Cdk4).,d another phosphorylation-deficient mutant, p130(PM19A) with 19 phosphorylation sites mutated, revealed that the p130-imposed G(1) block reflects cooperative growth-suppressive effects of phosphorylation-regulated E2F binding and phosphorylation-independent sequestration of cyclin E(A)-Cdk2 through the N-terminal cyclin binding motif of p130.
引用
收藏
页码:422 / 432
页数:11
相关论文
共 60 条
[1]   The retinoblastoma protein pathway in cell cycle control and cancer [J].
Bartek, J ;
Bartkova, J ;
Lukas, J .
EXPERIMENTAL CELL RESEARCH, 1997, 237 (01) :1-6
[2]   REGULATION OF THE RETINOBLASTOMA PROTEIN-RELATED P107 BY G(1) CYCLIN COMPLEXES [J].
BEIJERSBERGEN, RL ;
CARLEE, L ;
KERKHOVEN, RM ;
BERNARDS, R .
GENES & DEVELOPMENT, 1995, 9 (11) :1340-1353
[3]  
BERNARDS R, 1997, BIOCHIM BIOPHYS ACTA, V1333, P33
[4]   IDENTIFICATION OF THE MAJOR PHOSPHORYLATION SITES FOR PROTEIN-KINASE-C IN KIT/STEM CELL FACTOR-RECEPTOR IN-VITRO AND IN INTACT-CELLS [J].
BLUMEJENSEN, P ;
WERNSTEDT, C ;
HELDIN, CH ;
RONNSTRAND, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (23) :14192-14200
[5]  
Boyle WJ., 1991, METHOD ENZYMOL, V201, P110
[6]  
Brown VD, 1999, MOL CELL BIOL, V19, P3246
[7]   Requirements for cell cycle arrest by p16INK4a [J].
Bruce, JL ;
Hurford, RK ;
Classon, M ;
Koh, J ;
Dyson, N .
MOLECULAR CELL, 2000, 6 (03) :737-742
[8]   Dual cyclin-binding domains are required for p107 to function as a kinase inhibitor [J].
Castaño, E ;
Kleyner, Y ;
Dynlacht, BD .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (09) :5380-5391
[9]   Cdk2-dependent phosphorylation and functional inactivation of the pRB-related p130 protein in pRB(-), p16INK4A(+) tumor cells [J].
Cheng, LY ;
Rossi, F ;
Fang, WZ ;
Mori, T ;
Cobrinik, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (39) :30317-30325
[10]   pRB phosphorylation mutants reveal role of pRB in regulating S phase completion by a mechanism independent of E2F [J].
Chew, YP ;
Ellis, M ;
Wilkie, S ;
Mittnacht, S .
ONCOGENE, 1998, 17 (17) :2177-2186